Apoptosis of rat decidual cells: site specific initiation and related biochemical changes.

The artificially induced rat deciduoma serves as a model to study cellular changes associated with implantation in the endometrium. The stromal cells differentiate to form two types of decidual cells and are restricted to specific anatomical sites of the uterus. Programmed cell death starts in the antimesometrial area and expression of glutathione-S-transferase, an antioxidant enzyme, enhances in these cells as the deciduoma enters the regressive phase. The enzyme activity is significantly high compared with that of mesometrial decidual cells. Similarly, lipid peroxide content of antimesometrial decidual cells is high during this phase. DNA fragmentation, a feature of cells undergoing programmed cell death, is initiated in the antimesometrial area during regression of deciduoma.

Clot lysis: role of plasminogen activator inhibitors in haemostasis and therapy.

An unimpeded circulation of blood depends on the concerted activation of coagulation and fibrinolytic factors. The latter entails the controlled, localised conversion of plasma zymogen plasminogen to the active enzyme plasmin mediated by tissue-type plasminogen activator (tPA). Bulk of tPA activity is in the proximity of the endogenous plasminogen activator inhibitor (PAI) as an active complex. The advent of molecular biology techniques has enabled isolation of cDNA for the inhibitors PAI-1, PAI-2 and PAI-3 and data indicate that these belong to the serine protease inhibitor (Serpine) family with arginine as its active site but immunologically distinct from each other. Enhanced tPA or PAI-1 forms one of the risk factors related to cardiac diseases and thrombotic disorders. A line of therapy entails lowering of PAIs with concomitant increase in tPA levels leading to net enhancement in fibrinolytic activity. In as much as plasminogen activators exert their action extracellularly, they are accessible to inhibitors and therefore PAIs could have a therapeutic potential and serve as prognostic indicators in cancer. Documented findings related to the biochemical characteristics and therapeutic potential of PAIs are presented and discussed in the review.

Differential rate of protein synthesis by antimesometrial and mesometrial decidual cells of rat.

Incorporation, in vitro, of labelled methionine into proteins of artificially induced decidual tissue shows the presence of an active protein synthetic machinery in the decidualising endometrium of rats. During the progressive phase, antimesometrial and mesometrial decidual cells, restricted to specific anatomical sites of the endometrium, synthesize proteins at varying rates and the rate of incorporation of methionine into proteins of mesometrial decidual cells is higher. Resolution of proteins on acrylamide gels following SDS electrophoresis shows qualitative changes in endometrial proteins at different stages of morphogenesis of decidual cells. Results are discussed in relation to characteristic morphological features of two decidual cell populations and differential gene expression in the decidualising endometrium.

Enhanced expression of urokinase-type plasminogen activator in the rat endometrium following induction of decidualisation.

Urokinase-type plasminogen activator(uPA) assayed in uteri of cycling and deciduoma bearing rats shows detectable levels of this enzyme in endometrium. Zymographic analysis confirms uPA of decidual tissue and, following artificial induction of decidualisation, uPA activity constantly increases in the decidualising endometrium reaching a peak on day 9 of pseudopregnancy. Endometrial uPA of nonpregnant rats does not show any significant change during estrous cycle. Results are discussed in relation to expression of this activator in endometrium of rats during morphogenesis of decidual cells.